Showing results (111-120 of 350) with videos related to

Sort By:
Pageof 35
Neuroscience Letters|March 15, 1985
Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptorsL Steardo, M Knight, C A Tamminga, et al.
Neuroscience Letters|January 2, 1991
Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative diseaseZ Susel, T M Engber, S Kuo, et al.
Molecular Pharmacology|January 28, 1998
Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatumZ H Qin, Y Wang, M Nakai, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1990
Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilizationT M Engber, Z Susel, S Kuo, et al.
Revue Neurologique|January 1, 1986
Structural and functional studies of Gilles de la Tourette syndromeT N Chase, V Geoffrey, M Gillespie, et al.
Endocrinology|July 1, 1987
Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptideK Tanimoto, C A Tamminga, T N Chase, et al.
Annals of Neurology|August 1, 1986
Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observationsR Kurlan, A J Rubin, C Miller, et al.
Neurology|June 1, 1989
Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography studyK A Bamford, E D Caine, D K Kido, et al.
Annals of Neurology|August 1, 1988
Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's diseaseR Kurlan, D Goldblatt, R Zaczek, et al.
Neurology|November 13, 2002
Weight loss in early stage of Huntington's diseaseL Djoussé, B Knowlton, L A Cupples, et al.
Pageof 35